As a second demonstration of drug optimization, AutoClickChem was used to replicate a recent study conducted by Srinivasan et al. [22] wherein analogues of a known protein tyrosine phosphatase 1B (PTP1B) inhibitor, a potential treatment for type 2 diabetes, were optimized to improve binding affinity. The gene discussed is PTPN1; the disease is type 2 diabetes mellitus.